TrialInvestigational new drugs2013
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).
T Valentin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it